The HLA (human leukocyte antigen) system of cell surface proteins contributes to the regulation of the immune system. Yet certain antigens can make a significant difference. Patients with some types of HLA are at higher risk for autoimmune diseases, infectious diseases, or cancer. Thanks to an improved understanding of HLA function, researchers can now develop new cancer immunotherapies.
Our Product Manager for cells and media and HLA expert Lisa Hamelmann will talk you through the following topics:
- HLA restriction: finding and binding
- HLA and diseases: activating autoimmune responses
- HLA and cancer: how cancer cells escape recognition
- New therapeutic options: harnessing HLA for cancer immunotherapy
- HLA-typed cells: an important control system to test new immunotherapies
